2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 19.678.121 | 1.349.878 | 2 | ||
2020 | 0 | 10.999.659 | 48.296 | 1 |
Total number of partners: 76
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 76
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-03-01 | ERA-NET: Sustained collaboration of national and regional programmes in cancer research | TRANSCAN-3 | participant | 10.949.936 | 32 |
2021-01-01 | Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy | T2EVOLVE | participant | 8.728.185 | 29 |
2020-01-01 | NGS diagnostics in 21st century oncology: the best, for all, at all times | oncNGS | participant | 10.999.659 | 18 |